AptarGroup (ATR) delivered earnings and revenue surprises of +3.18% and +0.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

AptarGroup (ATR) reported $961.13 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 5.7%. EPS of $1.62 for the same period compares to $1.49 a year ...

Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report third quarter 2025 financial ...

The rapid rise of private equity’s influence over health care providers such as hospitals, nursing homes, and physicians’ ...